Evidence map›Paper›PMID 30934852›Full record

ArticleNutrients2019

Gamma-oryzanol Prevents LPS-induced Brain Inflammation and Cognitive Impairment in Adult Mice.

Andrea Mastinu, Sara Anna Bonini, Wiramon Rungratanawanich, Francesca Aria, Mariagrazia Marziano, Giuseppina Maccarinelli, Giulia Abate, Marika Premoli, Maurizio Memo, Daniela Uberti

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Nutrients · 2024
    Article
  8. Article
  9. The Bioactive Gamma-Oryzanol fromAntioxidants (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Prosocial Effects of NonpsychotropicCannabis and cannabinoid research · 2022
    Article
  14. Drought Resistance Loci in Recombinant Lines of IranianBiotech (Basel (Switzerland)) · 2021
    Article
  15. Competitive Ability Effects ofPlants (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Article
  18. Combined Effect of Impregnation with anMolecules (Basel, Switzerland) · 2021
    Article
  19. Article
  20. Biological Response ofPlants (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Andrea MastinuDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. andrea.mastinu@unibs.it.ORCID 0000-0002-8862-2896
Sara Anna BoniniDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. sara.bonini@unibs.it.ORCID 0000-0001-6571-5910
Wiramon RungratanawanichDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. w.rungratanawani@unibs.it.
Francesca AriaDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. f.aria@unibs.it.ORCID 0000-0003-1181-562X
Mariagrazia MarzianoDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. m.marziano@unibs.it.
Giuseppina MaccarinelliDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. giuseppina.maccarinelli@unibs.it.
Giulia AbateDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. g.abate001@unibs.it.ORCID 0000-0001-9161-3475
Marika PremoliDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. m.premoli002@unibs.it.ORCID 0000-0002-2948-7524
Maurizio MemoDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. maurizio.memo@unibs.it.
Daniela UbertiDepartment of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. daniela.uberti@unibs.it.
University of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRice (

methodsMice received 100 mg/kg γ-oryzanol (ORY) or vehicle once daily for 21 consecutive days and were then exposed to an inflammatory stimulus elicited by lipopolysaccharide (LPS). A novel object recognition test and mRNA expression of antioxidant and neuroinflammatory markers in the hippocampus were evaluated.

resultsORY treatment was able to improve cognitive performance during the neuroinflammatory response. Furthermore, phase II antioxidant enzymes such as heme oxygenase-1 (HO-1) and NADPH-dehydrogenase-quinone-1 (NQO1) were upregulated in the hippocampi of ORY and ORY+LPS mice. Lastly, γ-oryzanol showed a strong anti-inflammatory action by downregulating inflammatory genes after LPS treatment.

conclusionThese results suggest that chronic consumption of γ-oryzanol can revert the LPS-induced cognitive and memory impairments by promoting hippocampal antioxidant and anti-inflammatory molecular responses.

Indexed as

AnimalsAntioxidantsCognitive DysfunctionEncephalitisGene Expression RegulationHippocampusLipopolysaccharidesMaleMiceOryzaPhenylpropionatesUp-RegulationAntioxidantsgamma-oryzanolLipopolysaccharidesPhenylpropionatescognitive performanceneuroinflammationsecond-generation antioxidant enzymesγ-oryzanol

Identifiers

PMID30934852
PMCPMC6520753
OpenAlexW2928891605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.